524 related articles for article (PubMed ID: 29095961)
1. Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization.
Koromyslova AD; Hansman GS
PLoS Pathog; 2017 Nov; 13(11):e1006636. PubMed ID: 29095961
[TBL] [Abstract][Full Text] [Related]
2. Direct Blockade of the Norovirus Histo-Blood Group Antigen Binding Pocket by Nanobodies.
Kher G; Sabin C; Lun JH; Devant JM; Ruoff K; Koromyslova AD; von Itzstein M; Pancera M; Hansman GS
J Virol; 2023 Apr; 97(4):e0183322. PubMed ID: 36971561
[TBL] [Abstract][Full Text] [Related]
3. Nanobody binding to a conserved epitope promotes norovirus particle disassembly.
Koromyslova AD; Hansman GS
J Virol; 2015 Mar; 89(5):2718-30. PubMed ID: 25520510
[TBL] [Abstract][Full Text] [Related]
4. Nanobody-Mediated Neutralization Reveals an Achilles Heel for Norovirus.
Koromyslova AD; Devant JM; Kilic T; Sabin CD; Malak V; Hansman GS
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321816
[TBL] [Abstract][Full Text] [Related]
5. Structural Basis of Nanobodies Targeting the Prototype Norovirus.
Ruoff K; Kilic T; Devant J; Koromyslova A; Ringel A; Hempelmann A; Geiss C; Graf J; Haas M; Roggenbach I; Hansman G
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602609
[TBL] [Abstract][Full Text] [Related]
6. Epitope mapping of histo blood group antigens bound to norovirus VLPs using STD NMR experiments reveals fine details of molecular recognition.
Fiege B; Leuthold M; Parra F; Dalton KP; Meloncelli PJ; Lowary TL; Peters T
Glycoconj J; 2017 Oct; 34(5):679-689. PubMed ID: 28823097
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis for Human Norovirus Capsid Binding to Bile Acids.
Kilic T; Koromyslova A; Hansman GS
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355683
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability.
Hansman GS; Biertümpfel C; Georgiev I; McLellan JS; Chen L; Zhou T; Katayama K; Kwong PD
J Virol; 2011 Jul; 85(13):6687-701. PubMed ID: 21525337
[TBL] [Abstract][Full Text] [Related]
9. Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.
Koromyslova AD; Morozov VA; Hefele L; Hansman GS
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541855
[TBL] [Abstract][Full Text] [Related]
10. Human noroviruses' fondness for histo-blood group antigens.
Singh BK; Leuthold MM; Hansman GS
J Virol; 2015 Feb; 89(4):2024-40. PubMed ID: 25428879
[TBL] [Abstract][Full Text] [Related]
11. Structural analysis of a rabbit hemorrhagic disease virus binding to histo-blood group antigens.
Leuthold MM; Dalton KP; Hansman GS
J Virol; 2015 Feb; 89(4):2378-87. PubMed ID: 25505081
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for norovirus inhibition and fucose mimicry by citrate.
Hansman GS; Shahzad-Ul-Hussan S; McLellan JS; Chuang GY; Georgiev I; Shimoike T; Katayama K; Bewley CA; Kwong PD
J Virol; 2012 Jan; 86(1):284-92. PubMed ID: 22031945
[TBL] [Abstract][Full Text] [Related]
13. Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens.
Ali ES; Rajapaksha H; Carr JM; Petrovsky N
Antiviral Res; 2016 Sep; 133():14-22. PubMed ID: 27421712
[TBL] [Abstract][Full Text] [Related]
14. Chimeric GII.3/GII.6 norovirus capsid (VP1) proteins: characterization by electron microscopy, trypsin sensitivity and binding to histo-blood group antigens.
Ma S; Zheng L; Liu J; Wang W; Ma J; Cheng X; Ge L; Wang M; Huo Y; Shen S
Arch Virol; 2018 Dec; 163(12):3265-3273. PubMed ID: 30143876
[TBL] [Abstract][Full Text] [Related]
15. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
[TBL] [Abstract][Full Text] [Related]
16. Structural Basis for Norovirus Inhibition by Human Milk Oligosaccharides.
Weichert S; Koromyslova A; Singh BK; Hansman S; Jennewein S; Schroten H; Hansman GS
J Virol; 2016 May; 90(9):4843-4848. PubMed ID: 26889023
[TBL] [Abstract][Full Text] [Related]
17. Genogroup IV and VI canine noroviruses interact with histo-blood group antigens.
Caddy S; Breiman A; le Pendu J; Goodfellow I
J Virol; 2014 Sep; 88(18):10377-91. PubMed ID: 25008923
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody.
Shanker S; Czakó R; Sapparapu G; Alvarado G; Viskovska M; Sankaran B; Atmar RL; Crowe JE; Estes MK; Prasad BV
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):E5830-E5837. PubMed ID: 27647885
[TBL] [Abstract][Full Text] [Related]
19. Human Norovirus Interactions with Histo-Blood Group Antigens and Human Milk Oligosaccharides.
Schroten H; Hanisch FG; Hansman GS
J Virol; 2016 Jul; 90(13):5855-5859. PubMed ID: 27122582
[TBL] [Abstract][Full Text] [Related]
20. Treatment of norovirus particles with citrate.
Koromyslova AD; White PA; Hansman GS
Virology; 2015 Nov; 485():199-204. PubMed ID: 26295280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
